B-LYMPHOCYTE COUNT DECREASED side effect
What is B-LYMPHOCYTE COUNT DECREASED ?Drugs associated with B-LYMPHOCYTE COUNT DECREASED
CARBIDOPA CYCLOPHOSPHAMIDE HUMIRA MABTHERA METHOTREXATE PROGRAF RITUXAN TEGRETOLB-LYMPHOCYTE COUNT DECREASED : Carbidopa Side Effects Report #5648442-0
Physician from JAPAN reported CARBIDOPA AND LEVODOPA problem on Feb 25, 2008. Male patient, 78 years of age, was diagnosed with skin disorder, parkinson's disease and was treated with CARBIDOPA AND LEVODOPA. After drug was administered, patient experienced the following problems/side effects: b-lymphocyte count decreased, carotid artery stenosis, cerebral infarction, gamma-glutamyltransferase increased, haematocrit decreased, haemoglobin decreased, hemiparesis, hypoaesthesia, neutrophil count abnormal, . CARBIDOPA AND LEVODOPA dosage: 300 MG. During the same period patient was treated with PANTOSIN, KAMAG G, TAMSULOSIN, UBRETID, FAMOTIDINE, PREDONINE, COMTAN. Patient was hospitalized. Patient recovered.
B-LYMPHOCYTE COUNT DECREASED : Mabthera Side Effects Report #5664852-X
MABTHERA problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 07, 2008. Female patient was diagnosed with systemic lupus erythematosus, raynaud's phenomenon, osteoporosis, hypothyroidism, hypersensitivity, premature menopause and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: b-lymphocyte count decreased, progressive multifocal leukoencephalopathy, . MABTHERA dosage: 375 MG/M2, 1/WEEK. During the same period patient was treated with AMLODIPINE, CALCICHEW D, HYDROXYCHLOROQUINE SULPHATE, LEVOTHYROXINE, CLARITIN, NUVELLE. Patient died on 07/10/2006.
B-LYMPHOCYTE COUNT DECREASED : Carbidopa Side Effects Report #5634548-9
Physician from JAPAN reported CARBIDOPA AND LEVODOPA problem on Feb 15, 2008. Male patient, 78 years of age, was diagnosed with skin disorder, parkinson's disease and was treated with CARBIDOPA AND LEVODOPA. After drug was administered, patient experienced the following problems/side effects: b-lymphocyte count decreased, carotid artery stenosis, cerebral infarction, gamma-glutamyltransferase increased, haematocrit decreased, haemoglobin decreased, hemiparesis, neutrophil count abnormal, red blood cell count decreased, . CARBIDOPA AND LEVODOPA dosage: 300 MG. During the same period patient was treated with PANTOSIN, KAMAG G, TAMSULOSIN, UBRETID, FAMOTIDINE, PREDONINE, COMTAN. Patient was hospitalized. Patient recovered.
B-LYMPHOCYTE COUNT DECREASED : Mabthera Side Effects Report #5579736-5
MABTHERA problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Dec 27, 2007. Female patient was diagnosed with systemic lupus erythematosus, raynaud's phenomenon, osteoporosis, hypothyroidism, hypersensitivity, premature menopause and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: b-lymphocyte count decreased, progressive multifocal leukoencephalopathy, . MABTHERA dosage: 375 MG/M2, 1/WEEK. During the same period patient was treated with AMLODIPINE, CALCICHEW D, HYDROXYCHLOROQUINE SULPHATE, LEVOTHYROXINE, CLARITIN, NUVELLE. Patient died on 07/10/2006.
B-LYMPHOCYTE COUNT DECREASED : Rituxan Side Effects Report #5476324-6
Consumer or non-health professional from GERMANY reported RITUXAN problem on Sept 24, 2007. Female patient was diagnosed with burkitt's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: b-lymphocyte count decreased, . RITUXAN dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient recovered.
B-LYMPHOCYTE COUNT DECREASED : Cyclophosphamide Side Effects Report #5479878-9
CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from on Oct 01, 2007. Female patient, 52 years of age, was diagnosed with rheumatoid arthritis, psoriasis and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: b-lymphocyte count decreased, psoriasis, . CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with RITUXIMAB, TOPICAL STEROIDS. Patient recovered.
B-LYMPHOCYTE COUNT DECREASED : Cyclophosphamide Side Effects Report #5479879-0
Consumer or non-health professional from reported CYCLOPHOSPHAMIDE problem on Oct 01, 2007. Female patient, 25 years of age, was diagnosed with rheumatoid arthritis and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: b-lymphocyte count decreased, onycholysis, psoriasis, tendon rupture, uveitis, . CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with METHOTREXATE, SULFASALAZINE, CYCLOSPORINE, RITUXIMAB, METHYLPREDNISOLONE. Patient recovered.
B-LYMPHOCYTE COUNT DECREASED : Cyclophosphamide Side Effects Report #5479880-7
CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from on Oct 01, 2007. Female patient, 26 years of age, was diagnosed with systemic lupus erythematosus and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: b-lymphocyte count decreased, cerebral haemorrhage, onycholysis, psoriasis, thrombocytopenia, . CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with RITUXIMAB, DMARDS, STEROIDS, IMMUNE GLOBULIN INTRAVENOUS. Patient was hospitalized. Patient recovered.
B-LYMPHOCYTE COUNT DECREASED : Rituxan Side Effects Report #5429774-8
Physician from UNITED KINGDOM reported RITUXAN problem on Aug 20, 2007. Female patient was diagnosed with systemic lupus erythematosus, raynaud's phenomenon, osteoporosis, hypothyroidism, hypersensitivity, premature menopause and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: b-lymphocyte count decreased, progressive multifocal leukoencephalopathy, . RITUXAN dosage: 375 MG/M2, 1/WEEK. During the same period patient was treated with AMLODIPINE, CALCICHEW D, HYDROXYCHLOROQUINE SULPHATE, LEVOTHYROXINE, CLARITIN, NUVELLE. Patient died on 07/10/2006.
B-LYMPHOCYTE COUNT DECREASED : Humira Side Effects Report #5611623-6
HUMIRA problem was reported by a Physician from SPAIN on Jan 24, 2008. Male patient, weighting 20.90 lb, was diagnosed with juvenile arthritis, hypertension, prophylaxis, constipation and was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: antinuclear antibody positive, b-lymphocyte count decreased, bone marrow failure, constipation, cytomegalovirus infection, dyspnoea, haematuria, hepatosplenomegaly, . HUMIRA dosage: unknown. During the same period patient was treated with PREDNISONE, MYCOPHENOLATE MOFETIL, AMLODIPINE BESYLATE, BACTRIM, MACROGOL. Patient was hospitalized. Patient recovered.
B-LYMPHOCYTE COUNT DECREASED : Mabthera Side Effects Report #5589560-5
Consumer or non-health professional from UNITED KINGDOM reported MABTHERA problem on Jan 07, 2008. Female patient was diagnosed with systemic lupus erythematosus, raynaud's phenomenon, osteoporosis, hypothyroidism, hypersensitivity, premature menopause and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, b-lymphocyte count decreased, disease recurrence, herpes zoster, intestinal obstruction, pneumonia aspiration, post procedural pneumonia, progressive multifocal leukoencephalopathy, respiratory failure, . MABTHERA dosage: 375 MG/M2, 1/WEEK. During the same period patient was treated with AMLODIPINE, CALCICHEW D, HYDROXYCHLOROQUINE, LEVOTHYROXINE, CLARITIN, NUVELLE. Patient died on 07/10/2006.
B-LYMPHOCYTE COUNT DECREASED : Methotrexate Side Effects Report #5379846-1
METHOTREXATE problem was reported by a Physician from AUSTRALIA on June 21, 2007. Male patient, child 8 years of age, was diagnosed with t-cell type acute leukaemia and was treated with METHOTREXATE. After drug was administered, patient experienced the following problems/side effects: alopecia, b-lymphocyte count decreased, humoral immune defect, hypogammaglobulinaemia, lower respiratory tract infection, madarosis, rash papulosquamous, . METHOTREXATE dosage: unknown. During the same period patient was treated with VINCRISTINE, MERCAPTOPURINE. Patient recovered.
B-LYMPHOCYTE COUNT DECREASED : Prograf Side Effects Report #5403457-2
Physician from JAPAN reported PROGRAF problem on July 13, 2007. Female patient, 47 years of age, was diagnosed with renal transplant, kidney transplant rejection and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: agranulocytosis, b-lymphocyte count decreased, cytomegalovirus infection, dialysis, hypogammaglobulinaemia, kidney transplant rejection, myeloid maturation arrest, no therapeutic response, . PROGRAF dosage: unknown. During the same period patient was treated with PREDNISOLONE. Patient recovered.
B-LYMPHOCYTE COUNT DECREASED : Methotrexate Side Effects Report #5379846-1
METHOTREXATE problem was reported by a Physician from AUSTRALIA on June 21, 2007. Male patient, child 8 years of age, was diagnosed with t-cell type acute leukaemia and was treated with METHOTREXATE. After drug was administered, patient experienced the following problems/side effects: alopecia, b-lymphocyte count decreased, humoral immune defect, hypogammaglobulinaemia, lower respiratory tract infection, madarosis, rash papulosquamous, . METHOTREXATE dosage: unknown. During the same period patient was treated with VINCRISTINE, MERCAPTOPURINE. Patient recovered.
B-LYMPHOCYTE COUNT DECREASED : Prograf Side Effects Report #5403457-2
Physician from JAPAN reported PROGRAF problem on July 13, 2007. Female patient, 47 years of age, was diagnosed with renal transplant, kidney transplant rejection and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: agranulocytosis, b-lymphocyte count decreased, cytomegalovirus infection, dialysis, hypogammaglobulinaemia, kidney transplant rejection, myeloid maturation arrest, no therapeutic response, . PROGRAF dosage: unknown. During the same period patient was treated with PREDNISOLONE. Patient recovered.
B-LYMPHOCYTE COUNT DECREASED : Tegretol Side Effects Report #5683943-0
TEGRETOL problem was reported by a Consumer or non-health professional from JAPAN on Mar 25, 2008. Female patient, child 8 years of age, was diagnosed with convulsion, gastric ulcer, vitamin supplementation and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, b-lymphocyte count decreased, blood alkaline phosphatase increased, granulocytopenia, hepatic function abnormal, hypogammaglobulinaemia, . TEGRETOL dosage: 120 MG/DAY. During the same period patient was treated with ALEVIATIN, SELENICA, MYSTAN, PHENOBAL, TAKEPRON, PANCAL, ZONISAMIDE, URSO. Patient recovered.
B-LYMPHOCYTE COUNT DECREASED : Tegretol Side Effects Report #5636359-7
Consumer or non-health professional from JAPAN reported TEGRETOL problem on Feb 19, 2008. Female patient, child 8 years of age, was diagnosed with convulsion, gastric ulcer, vitamin supplementation and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, b-lymphocyte count decreased, blood alkaline phosphatase increased, granulocytopenia, hepatic function abnormal, hypogammaglobulinaemia, pyrexia, . TEGRETOL dosage: 120 MG/DAY. During the same period patient was treated with ALEVIATIN, SELENICA, MYSTAN, PHENOBAL, LANSOPRAZOLE, PANCAL, ZONISAMIDE, URSO. Patient was hospitalized. Patient recovered.